Iterative Upgrading of Small Molecular Tyrosine Kinase Inhibitors for EGFR Mutation in NSCLC: Necessity and Perspective

Molecular targeted therapy has been reported to have fewer adverse effects, and offer a more convenient route of administration, compared with conventional chemotherapy. With the development of sequencing technology, and research on the molecular biology of lung cancer, especially whole-genome infor...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Jing, Yang, Qian, Xu, Weiguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468657/
https://www.ncbi.nlm.nih.gov/pubmed/34575576
http://dx.doi.org/10.3390/pharmaceutics13091500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468657/
https://www.ncbi.nlm.nih.gov/pubmed/34575576
http://dx.doi.org/10.3390/pharmaceutics13091500

Ejemplares similares